Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enso (ENSO) vs Enzyme (MLN) Price & Performance

Price performance (Past 24H)

Key statistics

Enso vs Enzyme — how do they compare? Enso trades at Rp13,571 (market cap Rp278,64M, Rp288,18M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enso is far larger — about 2.1× Enzyme's market cap, and Enso's supply is capped (20,6M / 127,3M ENSO (17%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enso for 9 Days and Enzyme for 29 Days on average.

ENSOMLN
Market Cap
Rp278,64MRp134,13M
Volume (24h)
Rp288,18MRp104,56M
Circulating Supply
20,6M / 127,3M ENSO (17%)3,3M MLN
Typical Hold Time
9 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enso

ENSO is currently trading at Rp14,004 with a bearish technical outlook, showing sell signals across multiple indicators. The token trades below its pivot point of Rp14,764 with immediate support at Rp12,862. With only 17% of max supply in circulation and an average hold time of 9 days, the asset shows limited distribution but high turnover. No recent protocol updates or ecosystem developments were identified in current market data.

Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity (Rp282.98M market cap) and absence of recent fundamental developments. Investors should monitor for breaking ecosystem news that could shift sentiment.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENSO
50% Buy50% Sell
Avg holding period · 9 Days
MLN

No sentiment data available yet.

About Enso

Enso is a blockchain infrastructure protocol that simplifies cross-chain development through standardized components and execution logic. It connects multiple networks using reusable Actions and Shortcuts, allowing developers to integrate smart contracts without complex custom builds. With its intent-based architecture, users define desired outcomes while Enso handles routing and execution across chains efficiently.

Read more on ENSO

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN